Vivos Therapeutics (VVOS) Change in Receivables (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Change in Receivables of $188000.0 for Q1 2026, down 34.72% year-over-year from $288000.0 in Q1 2025, and up 134.0% quarter-over-quarter from -$553000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Change in Receivables (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Change in Receivables for 7 consecutive years, with $188000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 34.72% year-over-year to $188000.0; the TTM figure through Mar 2026 stood at $117000.0 (down 39.06% YoY), while the FY2025 annual figure was $217000.0, down 4.82% from the prior year.
- Change in Receivables grew to $188000.0 in Q1 2026 per VVOS's latest filing, from -$553000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $501000.0 in Q3 2025 and bottomed at -$553000.0 in Q4 2025.
- Historically, Change in Receivables has averaged -$21647.1 across 5 years, with a median of -$24000.0 in 2024.
- Annual changes were most pronounced in 2024 — Change in Receivables plunged 2283.33% — and 2025, when it surged 749.15%.
- Vivos Therapeutics' Change in Receivables stood at -$409000.0 in 2022, then surged by 93.64% to -$26000.0 in 2023, then rose by 7.69% to -$24000.0 in 2024, then slumped by 2204.17% to -$553000.0 in 2025, then soared by 134.0% to $188000.0 in 2026.
- Business Quant data shows VVOS's Change in Receivables at $188000.0 in Q1 2026, -$553000.0 in Q4 2025, and $501000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -331,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188,000.00 |
| Mar 31, 2026 | 188,000.00 |
| Dec 31, 2025 | -553,000.00 |
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | 501,000.00 |
| Sep 30, 2025 | 501,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Jun 30, 2025 | -19,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Dec 31, 2024 | -24,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | -131,000.00 |
| Jun 30, 2024 | -131,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Dec 31, 2023 | -26,000.00 |